Protagonist Therapeutics Inc (MEX:PTGX)
MXN 1,565.33 (0%) Market Cap: 148.07 Bil Enterprise Value: 138.64 Bil PE Ratio: 0 PB Ratio: 12.88 GF Score: 47/100

Protagonist Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 04, 2026 / 04:50AM GMT
Release Date Price: MXN1565.33
Tara Bancroft
Cowen and Company LLC - Analyst

I'm Tara Bancroft. I'm one of the senior biotech analysts here at TD Cowen, and I want to thank you for coming to TD Cowen's 46th annual health care conference. Our next session, we have a fireside chat with Protagonist, and it's my pleasure to introduce Dinesh Patel, the CEO of Protagonist. So thank you so much, Dinesh for being here with us. It's a pleasure to have you.

And I want to remind everyone out there, if you have burning questions, please do let me know we'll make sure you get heard,

Questions & Answers

Tara Bancroft
Cowen and Company LLC - Analyst

So, I guess, Dinesh, maybe we could start first with some high level thoughts on where Protagonist is today, maybe even hopes for the mid and long-term at a high level.

Dinesh Patel
Protagonist Therapeutics Inc - President, Chief Executive Officer, Director

Yeah. So, Tara, first and foremost, thanks for this opportunity. It's a great conference and it's a pleasure to be part of the conference.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot